UBS AM’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-509,179
| Closed | -$2.84M | – | 2695 |
|
|
2025
Q1 | $2.84M | Buy |
509,179
+473,600
| +1,331% | +$2.64M | ﹤0.01% | 1834 |
|
|
2024
Q4 | $287K | Buy |
35,579
+12,545
| +54% | +$101K | ﹤0.01% | 2616 |
|
|
2024
Q3 | $236K | Sell |
23,034
-19,286
| -46% | -$198K | ﹤0.01% | 2747 |
|
|
2024
Q2 | $299K | Buy |
+42,320
| New | +$299K | ﹤0.01% | 2722 |
|
|
2022
Q2 | – | Sell |
-13,033
| Closed | -$69.6K | – | 2747 |
|
|
2022
Q1 | $69.6K | Hold |
13,033
| – | – | ﹤0.01% | 2754 |
|
|
2021
Q4 | $192K | Hold |
13,033
| – | – | ﹤0.01% | 2770 |
|
|
2021
Q3 | $273K | Hold |
13,033
| – | – | ﹤0.01% | 2637 |
|
|
2021
Q2 | $231K | Buy |
13,033
+2,033
| +18% | +$36K | ﹤0.01% | 2694 |
|
|
2021
Q1 | $270K | Buy |
11,000
+3,600
| +49% | +$88.2K | ﹤0.01% | 2506 |
|
|
2020
Q4 | $250K | Buy |
+7,400
| New | +$250K | ﹤0.01% | 2453 |
|
|
2020
Q3 | – | Sell |
-12,775
| Closed | -$431K | – | 2503 |
|
|
2020
Q2 | $431K | Buy |
+12,775
| New | +$431K | ﹤0.01% | 2178 |
|